Abstract
Lesion characteristics determined by angiography after balloon angioplasty such as residual dimeter stenosis (DS) or dissection type has been used to determine the treatment method of drug-coated balloon (DCB) or metal stent for de novo coronary lesions. The aim of this study is to identify angiographic and functional mismatch using residual DS, dissection type and fractional flow reserve (FFR). Baseline and post-balloon parameters were obtained from 151 patients with 167 lesions. Angiographically significant parameters after balloon angioplasty are residual DS > 30% or dissection type C or more. Post-balloon FFR cutoff value of 0.75 was used to define functionally significant lesions. The weak correlation was found between residual DS and post-balloon FFR (r = − 0.317, p < 0.001). There were 68.7% of mismatch population (residual DS > 30% and post-balloon FFR ≥ 0.75) and 7.1% of reverse mismatch population (residual DS ≤ 30% and post-balloon FFR < 0.75). All reverse mismatch lesions were found in left anterior descending artery. There was no correlation between dissection severity and post-balloon FFR (p = 0.654). In high post-balloon FFR group, long-term clinical outcomes showed no difference between DCB and stent groups with (p = 0.788) or without (p = 0.426) the adjustment of lesion characteristics. There were high frequencies of mismatch between angiographic lesion characteristics and FFR values after balloon angioplasty. Post-balloon FFR measurements may be safe and effective compared to angiography-guided treatment if DCB only treatment is considered.
Similar content being viewed by others
Abbreviations
- BA:
-
Balloon angioplasty
- DCB:
-
Drug-coated balloon
- DS:
-
Diameter stenosis
- FFR:
-
Fractional flow reserve
References
Byrne RA, Neumann FJ, Mehilli J et al (2013) Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. Lancet 381:461–467. https://doi.org/10.1016/s0140-6736(12)61964-3
Rittger H, Brachmann J, Sinha AM et al (2012) A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study. J Am Coll Cardiol 59:1377–1382. https://doi.org/10.1016/j.jacc.2012.01.015
Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Bohm M, Speck U (2006) Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 355:2113–2124. https://doi.org/10.1056/NEJMoa061254
Unverdorben M, Vallbracht C, Cremers B et al (2009) Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 119:2986–2994. https://doi.org/10.1161/circulationaha.108.839282
Jeger RV, Farah A, Ohlow MA et al (2018) Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial. Lancet 392:849–856. https://doi.org/10.1016/s0140-6736(18)31719-7
Ann SH, Balbir Singh G, Lim KH, Koo BK, Shin ES (2016) Anatomical and physiological changes after paclitaxel-coated balloon for atherosclerotic de novo coronary lesions: Serial IVUS-VH and FFR Study. PLoS ONE 11:e0147057. https://doi.org/10.1371/journal.pone.0147057
Ann SH, Her AY, Singh GB, Okamura T, Koo BK, Shin ES (2016) Serial morphological and functional assessment of the paclitaxel-coated balloon for de novo lesions. Rev Esp Cardiol 69:1026–1032. https://doi.org/10.1016/j.rec.2016.03.026
Her AY, Shin ES, Lee JM, Garg S, Doh JH, Nam CW, Koo BK (2018) Paclitaxel-coated balloon treatment for functionally nonsignificant residual coronary lesions after balloon angioplasty. Int J Cardiovasc Imaging 34:1339–1347. https://doi.org/10.1007/s10554-018-1351-z
Shin ES, Ann SH, Balbir Singh G, Lim KH, Kleber FX, Koo BK (2016) Fractional flow reserve-guided paclitaxel-coated balloon treatment for de novo coronary lesions. Catheter Cardiovasc Interv 88:193–200. https://doi.org/10.1002/ccd.26257
Kleber FX, Rittger H, Bonaventura K et al (2013) Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group. Clin Res Cardiol 102:785–797. https://doi.org/10.1007/s00392-013-0609-7
Huber MS, Mooney JF, Madison J, Mooney MR (1991) Use of a morphologic classification to predict clinical outcome after dissection from coronary angioplasty. Am J Cardiol 68:467–471. https://doi.org/10.1016/0002-9149(91)90780-o
Rogers JH, Lasala JM (2004) Coronary artery dissection and perforation complicating percutaneous coronary intervention. J Invasive Cardiol 16:493–499
Jang HJ, Koo BK, Lee HS et al (2013) Safety and efficacy of a novel hyperaemic agent, intracoronary nicorandil, for invasive physiological assessments in the cardiac catheterization laboratory. Eur Heart J 34:2055–2062. https://doi.org/10.1093/eurheartj/eht040
Bech GJ, Pijls NH, De Bruyne B, Peels KH, Michels HR, Bonnier HJ, Koolen JJ (1999) Usefulness of fractional flow reserve to predict clinical outcome after balloon angioplasty. Circulation 99:883–888
Anderson HV, Roubin GS, Leimgruber PP, Cox WR, Douglas JS Jr, King SB 3rd, Gruentzig AR (1986) Measurement of transstenotic pressure gradient during percutaneous transluminal coronary angioplasty. Circulation 73:1223–1230
De Bruyne B, Pijls NH, Kalesan B et al (2012) Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367:991–1001. https://doi.org/10.1056/NEJMoa1205361
Park SJ, Kang SJ, Ahn JM et al (2012) Visual-functional mismatch between coronary angiography and fractional flow reserve. JACC Cardiovasc Interv 5:1029–1036. https://doi.org/10.1016/j.jcin.2012.07.007
Kim HY, Lim HS, Doh JH et al (2016) Physiological severity of coronary artery stenosis depends on the amount of myocardial mass subtended by the coronary artery. JACC Cardiovasc Interv 9:1548–1560. https://doi.org/10.1016/j.jcin.2016.04.008
Bech GJ, De Bruyne B, Pijls NH et al (2001) Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation 103:2928–2934
Berger A, Botman KJ, MacCarthy PA, Wijns W, Bartunek J, Heyndrickx GR, Pijls NH, De Bruyne B (2005) Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. J Am Coll Cardiol 46:438–442. https://doi.org/10.1016/j.jacc.2005.04.041
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chung, JH., Lee, K.E., Her, AY. et al. Comparison of fractional flow reserve and angiographic characteristics after balloon angioplasty in de novo coronary lesions. Int J Cardiovasc Imaging 35, 1945–1954 (2019). https://doi.org/10.1007/s10554-019-01649-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-019-01649-y